Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000473161 | SCV000545347 | pathogenic | Li-Fraumeni syndrome | 2023-05-13 | criteria provided, single submitter | clinical testing | This premature translational stop signal has been observed in individual(s) with breast cancer (PMID: 25877891, 25927356). This sequence change creates a premature translational stop signal (p.Tyr107*) in the TP53 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TP53 are known to be pathogenic (PMID: 20522432). This variant is not present in population databases (gnomAD no frequency). ClinVar contains an entry for this variant (Variation ID: 406599). For these reasons, this variant has been classified as Pathogenic. |